Dr. Kaylen Silverberg was asked by Teva Pharmaceuticals to present the results of their nationwide multicenter trial evaluating the efficacy of a new progesterone vaginal ring in patients undergoing IVF at the recent annual meeting of the American College of Obstetricians and Gynecologists, May. Dr. Silverberg was one of the principal investigators of this trial. The study suggests that the ring, if approved by the FDA, may offer patients another alternative to the painful intramuscular injections of progesterone that used to be standard IVF treatment.
Recently the study abstract was released in the American College of Obstetrics and Gynecology Abstract book. The paper is now available in the Texas Fertility Center Research Library papers section.
The study poster is also available on online at http://www.txfertility.com/Research/Posters
Efficacy of a progesterone vaginal ring versus progesterone gel for luteal phase supplementation – Kaylen M. Silverberg, MDa & Brandon K. Howard, PhDb